Phase 1 Alzheimer Disease, Early Onset trials recruiting now

All Alzheimer Disease, Early Onset trials, every phase

Phase 1 Alzheimer Disease, Early Onset trials

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
  NCT07328451 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
  NCT04500847 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 2 locations
• Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
  NCT07221344 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.